SCHEMBL3852745

SCHEMBL3852745

Brc1ccc2nccc(N3CCC(Oc4ccccn4)CC3)c2c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 3/20 0.55
CHRM4 P08173 2/20 0.48
PDE3B Q13370 1/20 0.48
PDE3A Q14432 1/20 0.48
PDE10A Q9Y233 1/20 0.48
AVPR1A P37288 6/20 0.44
IRAK4 Q9NWZ3 1/20 0.41
ADRB2 P07550 1/20 0.39
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
EPHX2 P34913 1/20 0.38
SCN9A Q15858 1/20 0.37
RET P07949 1/20 0.36
HTT P42858 2/20 0.36
KCNH2 Q12809 2/20 0.35
PPARG P37231 1/20 0.35
ATM Q13315 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NCOR2 Q9Y618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13874000 0.82 CHRM4 (0.56) NCF1CHRM4PDE3BPDE3APDE10A
SCHEMBL1544187 0.81 NCF1 (0.62) NCF1CHRM4IRAK4ADRB2HCRTR1
SCHEMBL13874379 0.81 NCF1 (0.48) NCF1CHRM4PDE3BPDE3APDE10A
SCHEMBL14145427 0.80 NCF1 (0.50) NCF1CHRM4PDE3BPDE3APDE10A
SCHEMBL3845232 0.80 NCF1 (0.50) NCF1CHRM4PDE3BPDE3APDE10A
SCHEMBL3848074 0.79 NCF1 (0.48) NCF1CHRM4PDE10AIRAK4HCRTR1
SCHEMBL14145430 0.78 CHRM4 (0.46) NCF1CHRM4PDE3BPDE3APDE10A
Hydrochloric Acid SCHEMBL3850318 0.78 CHRM4 (0.45) NCF1CHRM4PDE3BPDE3APDE10A
SCHEMBL13874541 0.78 CHRM4 (0.45) NCF1CHRM4PDE3BPDE3APDE10A
SCHEMBL3847011 0.78 CHRM4 (0.56) NCF1CHRM4PDE3BPDE3APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed